What is the translation of " RESPONSE AND TOLERABILITY " in Slovenian?

• odziv in prenašanje

Examples of using Response and tolerability in English and their translations into Slovenian

Dose escalation should be based upon clinical response and tolerability.
Zvišanje odmerka mora biti osnovano na kliničnem odgovoru in prenosljivosti.

Based on individual patient response and tolerability, the dose may be increased to 300 mg per day after 1 week.
Glede na bolnikov odziv in prenašanje je mogoče odmerek čez 1 teden zvečati na 300 mg na dan.

The dose may be increased to 80 mg daily, according to the response and tolerability.
Odmerek je mogoče glede na odziv in prenašanje zvečati do 80 mg na dan.

Based on individual patient response and tolerability, the dosage may be increased to 300 mg per day after 1 week.
Glede na bolnikov odziv in prenašanje se lahko odmerek po enem tednu poveča na 300 mg na dan.

The dose may be increased to 6 mg once daily based on clinical response and tolerability.
Odmerek se lahko poveča na 6 mg enkrat na dan glede na klinični odziv in prenosljivost zdravila.

Additionally, patient response and tolerability should be carefully monitored and dose should be adapted accordingly.
Dodatno je treba skrbno spremljati bolnikov odziv in prenašanje ter odmerek ustrezno prilagoditi.

Dose should be individualised according to the patient's response and tolerability.
Odmerek moramo prilagoditi odzivu na zdravljenje in prenašanju zdravila vsakega bolnika posebej.

Depending on the clinical response and tolerability in the individual patient, the dose can be increased to 10 mg twice daily.
Odvisno od kliničnega odziva in prenašanja zdravila pri posameznem bolniku se lahko odmerek poveča na 10 mg dvakrat na dan.

Dose increase or reduction is recommended based on patient response and tolerability.
Odmerek je treba povečati ali zmanjšati v skladu z bolnikovim odzivom na zdravljenje in prenašanjem zdravila.

Depending on the patient's response and tolerability for Intuniv the recommended maintenance dose range is 0.05-0.12 mg/kg/day.
Odvisno od bolnikovega odziva na zdravilo in prenašanja zdravila Intuniv je razpon priporočenih vzdrževalnih odmerkov 0,05-0,12 mg/kg/dan.

The dose can be increased to 10 mg twice daily based on individual clinical response and tolerability.
Odmerek se lahko zviša na 10 mg dvakrat na dan na podlagi kliničnega odziva in prenašanja zdravila posameznika.

Based on drug exposure, pharmacodynamic response and tolerability, a lower dose of Pegasys is not needed in the geriatric patient(see section 4.2).
Glede na izpostavljenost, farmakodinamični odziv in prenašanje pri starejših bolnikih ni potreben nižji odmerek zdravila Pegasys(glejte poglavje 4. 2).

Dose increases in patients with mild and moderate hepatic impairment should be based on clinical response and tolerability.
Povečevanje odmerkov pri bolnikih z blago in zmerno okvaro jeter mora temeljiti na kliničnem odzivu in prenašanju.

Depending upon individual clinical response and tolerability at a dose of 8 mg/day(16 ml/day) the dose may be increased by increments of 2 mg/day(4 ml/day) to.
Glede na individualni klinični odziv in prenašanje pri odmerku 8 mg/dan(16 ml/dan) se lahko odmerek zvečuje postopoma po 2 mg/dan(4 ml/dan) do.

Dosing intervals should be modified according to clinical response and tolerability(see sections 4.2 and 4.4).
Časovne presledke med posameznimi odmerki je treba spreminjati glede na klinični odziv in prenašanje(glejte poglavji 4.2 in 4.4).

Thereafter, based on individual patient response and tolerability, the dose can be further increased in 300 mg/ day increments every 2-3 days up to a maximum dose of 3600 mg/ day.
Potem je mogoče odmerek glede na bolnikov odziv in prenašanje povečevati po 300 mg/ dan na 2 do 3 dni do največjega odmerka 3600 mg/ dan.

Unlike the other three PDE-5 inhibitors, Cialis can be taken once-a-day, every day as a low dose(usually 2.5-5 mg/day depending on response and tolerability).
Za razliko od drugih treh zaviralcev PDE-5 se lahko Cialis jemlje enkrat na dan, vsak dan kot nizek odmerek(običajno 2,5-5 mg/ dan, odvisno od odziva in prenašanja).

According to clinical response and tolerability, after a minimum of 2 days the dose may be increased by 200 mg/ day, to the maximum recommended dose of 600 mg/ day.
Glede na klinični odziv in prenašanje zdravila lahko čez najmanj 2 dni odmerek zvečamo za 200 mg/ dan na največji priporočeni odmerek, ki je 600 mg/ dan.

Vimpat treatment initiation pack contains 4 different packages(one for each tablet strength) with 14 tablets each, for the first 2 to 4 weeks of therapy depending on the patient's response and tolerability.
Paket zdravila Vimpat za začetek zdravljenja vsebuje 4 različna pakiranja(eno za vsako jakost tablet), vsako s po 14 tabletami, ki glede na bolnikov odziv in prenašanje zdravila zadostuje za prva 2 do 4 tedne zdravljenja.

According to clinical response and tolerability, after a minimum of 2 days the dose may be increased by 200 mg/day, to the maximum recommended dose of 600 mg/day(15 ml/day).
Glede na klinični odziv in prenašanje zdravila lahko čez najmanj 2 dni odmerek povečamo za 200 mg/dan do največjega priporočenega odmerka, ki je 600 mg/dan(15 ml/dan).

The following indication was agreed by the CHMP:“ Gabapentin is indicated as monotherapy in the treatment of partial seizures with and without secondary generalization in adults and adolescents aged 12 years and above.” The posology is to be adjusted individually depending on response and tolerability.
Gabapentin je indiciran kot monoterapija pri odraslih in mladostnikih, starih 12 let in več, ki imajo parcialne napade s sekundarno generalizacijo ali brez nje.“ Odmerjanje je potrebno prilagoditi posamezniku glede na odziv in prenašanje.

According to clinical response and tolerability, the dose may be increased by 200 mg/ day increments, as frequently as every two days, up to a maximum recommended dose of 1000 mg/ day.
Glede na klinični odziv in prenašanje zdravila lahko odmerek zvečujemo postopoma po 200 mg/ dan celo vsak drugi dan do največjega priporočenega odmerka 1000 mg/ dan.

If an adequate reduction in alkaline phosphatase and/or total bilirubin has not been achieved after 3 months of OCALIVA 5 mg once weekly, and the patient is tolerating the medicinal product, increase the dose of OCALIVA to 5 mg twice weekly(at least three days apart between doses) and subsequently to 10 mg twice weekly(at least three days apart between doses) depending on response and tolerability.
Če po 3 mesecih zdravljenja z zdravilom OCALIVA pri odmerku 5 mg enkrat na teden ustrezno zmanjšanje alkalne fosfataze in/ali skupnega bilirubina ni doseženo, bolnik pa zdravilo prenaša, zvečajte odmerek zdravila OCALIVA na 5 mg dvakrat na teden(z razmikom vsaj 3 dni med odmerkoma) in pozneje na 10 mg dvakrat na teden(z razmikom vsaj 3 dni med odmerkoma) glede na odziv in prenašanje.

Depending upon individual clinical response and tolerability at a dose of 8 mg/day, the dose may be increased up to 12 mg/day, which may be effective in some patients(see section 4.4).
Glede na individualni klinični odziv in prenašanje pri odmerku 8 mg/dan se lahko odmerek zvečuje do 12 mg/dan, ki je pri nekaterih bolnikih lahko učinkovit(glejte poglavje 4.4).

According to clinical response and tolerability, the dose may be increased by 400 mg/ day increments, as frequently as every two days, up to a maximum recommended dose as indicated in the table below.
Glede na klinični odziv in prenašanje zdravila lahko odmerek zvečujemo postopoma po 400 mg/ dan celo vsak drugi dan do največjega priporočenega odmerka, navedenega v spodnji preglednici.

Based on individual patient response and tolerability, the dosage may be increased to 300 mg per day after an interval of 3 to 7 days, and if needed, to a maximum dose of 600 mg per day after an additional 7-day interval.
Glede na bolnikov odziv in prenašanje je mogoče čez 3 do 7 dni odmerek zvečati na 300 mg na dan in- če je potrebno- čez nadaljnjih 7 dni na največji odmerek 600 mg na dan.

The dose may be increased based on clinical response and tolerability by increments of 2 mg(either weekly or every 2 weeks as per half-life considerations described below) to a maintenance dose of 4 mg/day to 8 mg/day.
Odmerek se lahko zvečuje na podlagi kliničnega odziva in prenašanja postopoma po 2 mg(bodisi vsak teden bodisi vsaka 2 tedna ob upoštevanju razpolovnega časa, kot je opisano spodaj) do vzdrževalnega odmerka 4 mg/dan do.